GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sansure Biotech Inc (SHSE:688289) » Definitions » YoY EPS Growth

Sansure Biotech (SHSE:688289) YoY EPS Growth : 40.00% (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Sansure Biotech YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Sansure Biotech's YoY EPS Growth for the quarter that ended in Mar. 2024 was 40.00%.

Sansure Biotech's Earnings per Share (Diluted) for the three months ended in Mar. 2024 was ¥0.14.


Sansure Biotech YoY EPS Growth Historical Data

The historical data trend for Sansure Biotech's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sansure Biotech YoY EPS Growth Chart

Sansure Biotech Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EPS Growth
Get a 7-Day Free Trial - 6,300.00 -19.55 -13.12 -81.27

Sansure Biotech Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -91.07 -92.59 -56.79 -80.70 40.00

Sansure Biotech YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Sansure Biotech's YoY EPS Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EPS Growth (A: Dec. 2023 )
=(Earnings per Share (Diluted) (A: Dec. 2023 )-Earnings per Share (Diluted) (A: Dec. 2022 ))/ | Earnings per Share (Diluted) (A: Dec. 2022 ) |
=(0.62-3.31)/ | 3.31 |
=-81.27 %

Sansure Biotech's YoY EPS Growth for the quarter that ended in Mar. 2024 is calculated as:

YoY EPS Growth (Q: Mar. 2024 )
=(Earnings per Share (Diluted) (Q: Mar. 2024 )-Earnings per Share (Diluted) (Q: Mar. 2023 )) / | Earnings per Share (Diluted) (Q: Mar. 2023 )) |
=(0.14-0.1)/ | 0.1 |
=40.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sansure Biotech YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Sansure Biotech's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Sansure Biotech (SHSE:688289) Business Description

Traded in Other Exchanges
N/A
Address
No. 680, Lusong Road, Changsha High-tech Industrial Development Zone, Hunan Province, Changsha, CHN, 410205
Sansure Biotech Inc is engaged in production and sales of diagnostic reagents and instruments. The company produces Class I medical devices, Class II medical devices, Class III medical devices, general instruments and meters, medical raw materials, medical laboratory equipment and appliances, and medical accessories.

Sansure Biotech (SHSE:688289) Headlines

No Headlines